Pharmaceutical Giant Joining Forces With Leading iPS Cell Institute

TOKYO, JAPAN - APRIL 17: Nobel Prize laureate and Kyoto University's Center for iPS Cell Research and Application (CiRA) director Shinya Yamanaka (R) shakes hands with Takeda Pharmaceutical president Christophe Weber (L) shake hands during a press conference on April 17, 2015 in Tokyo, Japan. Japan's largest pharmaceutical company plans to invest up to 2 billion Japanese yen (16.8 million U.S. dollars) a year over a decade, CiRA will provide the technology it uses to create iPS cells to Takeda, which in turn will share its technology for manufacturing pharmaceuticals along with its knowledge about chemicals that can conceivably be turned into new medicines. (Photo by The Asahi Shimbun via Getty Images)
TOKYO, JAPAN - APRIL 17: Nobel Prize laureate and Kyoto University's Center for iPS Cell Research and Application (CiRA) director Shinya Yamanaka (R) shakes hands with Takeda Pharmaceutical president Christophe Weber (L) shake hands during a press conference on April 17, 2015 in Tokyo, Japan. Japan's largest pharmaceutical company plans to invest up to 2 billion Japanese yen (16.8 million U.S. dollars) a year over a decade, CiRA will provide the technology it uses to create iPS cells to Takeda, which in turn will share its technology for manufacturing pharmaceuticals along with its knowledge about chemicals that can conceivably be turned into new medicines. (Photo by The Asahi Shimbun via Getty Images)
Pharmaceutical Giant Joining Forces With Leading iPS Cell Institute
PURCHASE A LICENSE
How can I use this image?
kr. 3.000,00
DKK

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.
Credit:
The Asahi Shimbun / Contributor
Editorial #:
470063366
Collection:
The Asahi Shimbun
Date created:
April 17, 2015
Upload date:
License type:
Release info:
Not released. More information
Source:
The Asahi Shimbun
Object name:
84797800
Max file size:
2824 x 2793 px (9.41 x 9.31 in) - 300 dpi - 5 MB